Kopra Bio
YC S24 · Active · Genetically engineered viruses that teach your immune system to kill…
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW23 | |
| Other | Active | YCW24 | |
| Other | Active | YCW24 | |
| Other | Active | YCS22 | |
| Other | Active | YCW22 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW24 | |
| Other | Active | YCW18 | |
| AI | Active | YCS22 | |
| Other | Public | YCW15 | |
| Other | Active | YCS21 |
Also from S24
All of S24About Kopra Bio
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
- YC batch
- S24 · Summer 2024
- Status, per YC
- Active
- Category
- Other
- Team size
- 2
- Location
- San Francisco, CA, USA
- Checked
- 35m ago
YC tags: Gene Therapy, Synthetic Biology, Biotech, Therapeutics, Oncology
Kopra Bio: questions
Which YC batch was Kopra Bio in?
Kopra Bio was in Y Combinator's Summer 2024 batch (S24).
Is Kopra Bio still active?
Y Combinator lists Kopra Bio as active.
Where is Kopra Bio based?
Kopra Bio lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.